Logo image of AAQ1.DE

AAP IMPLANTATE (AAQ1.DE) Stock Fundamental Analysis

FRA:AAQ1 - Deutsche Boerse Ag - DE000A3H2101 - Common Stock - Currency: EUR

1.8  -0.07 (-3.74%)

Fundamental Rating

2

Taking everything into account, AAQ1 scores 2 out of 10 in our fundamental rating. AAQ1 was compared to 60 industry peers in the Health Care Equipment & Supplies industry. AAQ1 has a bad profitability rating. Also its financial health evaluation is rather negative. AAQ1 is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year AAQ1 has reported negative net income.
AAQ1 had a negative operating cash flow in the past year.
In the past 5 years AAQ1 always reported negative net income.
AAQ1 had a negative operating cash flow in each of the past 5 years.
AAQ1.DE Yearly Net Income VS EBIT VS OCF VS FCFAAQ1.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10M -10M

1.2 Ratios

Looking at the Return On Assets, with a value of -26.54%, AAQ1 is doing worse than 72.73% of the companies in the same industry.
AAQ1's Return On Equity of -41.50% is on the low side compared to the rest of the industry. AAQ1 is outperformed by 67.27% of its industry peers.
Industry RankSector Rank
ROA -26.54%
ROE -41.5%
ROIC N/A
ROA(3y)-16.66%
ROA(5y)-33.86%
ROE(3y)-28.99%
ROE(5y)-55.37%
ROIC(3y)N/A
ROIC(5y)N/A
AAQ1.DE Yearly ROA, ROE, ROICAAQ1.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20 -20 -40 -60 -80 -100

1.3 Margins

AAQ1's Gross Margin of 84.83% is amongst the best of the industry. AAQ1 outperforms 90.91% of its industry peers.
In the last couple of years the Gross Margin of AAQ1 has declined.
The Profit Margin and Operating Margin are not available for AAQ1 so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 84.83%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.19%
GM growth 5Y-2.35%
AAQ1.DE Yearly Profit, Operating, Gross MarginsAAQ1.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 100 -100

More info and screens

3

2. Health

2.1 Basic Checks

AAQ1 does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for AAQ1 has been increased compared to 1 year ago.
Compared to 5 years ago, AAQ1 has more shares outstanding
AAQ1 has a worse debt/assets ratio than last year.
AAQ1.DE Yearly Shares OutstandingAAQ1.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M 8M
AAQ1.DE Yearly Total Debt VS Total AssetsAAQ1.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M

2.2 Solvency

Based on the Altman-Z score of 0.30, we must say that AAQ1 is in the distress zone and has some risk of bankruptcy.
AAQ1 has a worse Altman-Z score (0.30) than 67.27% of its industry peers.
AAQ1 has a Debt/Equity ratio of 0.17. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of AAQ1 (0.17) is better than 78.18% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.17
Debt/FCF N/A
Altman-Z 0.3
ROIC/WACCN/A
WACC6.67%
AAQ1.DE Yearly LT Debt VS Equity VS FCFAAQ1.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20M 40M

2.3 Liquidity

A Current Ratio of 2.12 indicates that AAQ1 has no problem at all paying its short term obligations.
AAQ1 has a better Current ratio (2.12) than 63.64% of its industry peers.
AAQ1 has a Quick Ratio of 1.03. This is a normal value and indicates that AAQ1 is financially healthy and should not expect problems in meeting its short term obligations.
AAQ1's Quick ratio of 1.03 is in line compared to the rest of the industry. AAQ1 outperforms 52.73% of its industry peers.
Industry RankSector Rank
Current Ratio 2.12
Quick Ratio 1.03
AAQ1.DE Yearly Current Assets VS Current LiabilitesAAQ1.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M

More info and screens

4

3. Growth

3.1 Past

The earnings per share for AAQ1 have decreased strongly by -43.53% in the last year.
AAQ1 shows a decrease in Revenue. In the last year, the revenue decreased by -0.33%.
The Revenue has been growing slightly by 1.26% on average over the past years.
EPS 1Y (TTM)-43.53%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%21.72%
Revenue 1Y (TTM)-0.33%
Revenue growth 3Y7.17%
Revenue growth 5Y1.26%
Sales Q2Q%121.74%

3.2 Future

Based on estimates for the next years, AAQ1 will show a very strong growth in Earnings Per Share. The EPS will grow by 35.68% on average per year.
The Revenue is expected to grow by 12.81% on average over the next years. This is quite good.
EPS Next Y54.55%
EPS Next 2Y35.68%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year15.04%
Revenue Next 2Y15.21%
Revenue Next 3Y19.72%
Revenue Next 5Y12.81%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
AAQ1.DE Yearly Revenue VS EstimatesAAQ1.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 10M 20M 30M
AAQ1.DE Yearly EPS VS EstimatesAAQ1.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 0 -1 -2

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

AAQ1 reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year AAQ1 is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
AAQ1.DE Price Earnings VS Forward Price EarningsAAQ1.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 -20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
AAQ1.DE Per share dataAAQ1.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5

4.3 Compensation for Growth

A more expensive valuation may be justified as AAQ1's earnings are expected to grow with 35.68% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y35.68%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for AAQ1!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

AAP IMPLANTATE

FRA:AAQ1 (3/6/2025, 7:00:00 PM)

1.8

-0.07 (-3.74%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-14 2024-11-14
Earnings (Next)04-30 2025-04-30/amc
Inst Owners17.31%
Inst Owner ChangeN/A
Ins Owners6.61%
Ins Owner ChangeN/A
Market Cap25.04M
Analysts42.22
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 2.18
P/FCF N/A
P/OCF N/A
P/B 2.03
P/tB 2.4
EV/EBITDA N/A
EPS(TTM)-0.62
EYN/A
EPS(NY)-0.07
Fwd EYN/A
FCF(TTM)-0.2
FCFYN/A
OCF(TTM)-0.18
OCFYN/A
SpS0.83
BVpS0.89
TBVpS0.75
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -26.54%
ROE -41.5%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 84.83%
FCFM N/A
ROA(3y)-16.66%
ROA(5y)-33.86%
ROE(3y)-28.99%
ROE(5y)-55.37%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.19%
GM growth 5Y-2.35%
F-Score2
Asset Turnover0.59
Health
Industry RankSector Rank
Debt/Equity 0.17
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 18.26%
Cap/Sales 2.44%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.12
Quick Ratio 1.03
Altman-Z 0.3
F-Score2
WACC6.67%
ROIC/WACCN/A
Cap/Depr(3y)27.5%
Cap/Depr(5y)21.44%
Cap/Sales(3y)4.02%
Cap/Sales(5y)6.17%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-43.53%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%21.72%
EPS Next Y54.55%
EPS Next 2Y35.68%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-0.33%
Revenue growth 3Y7.17%
Revenue growth 5Y1.26%
Sales Q2Q%121.74%
Revenue Next Year15.04%
Revenue Next 2Y15.21%
Revenue Next 3Y19.72%
Revenue Next 5Y12.81%
EBIT growth 1Y-48.66%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year89.19%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y31.5%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y27.07%
OCF growth 3YN/A
OCF growth 5YN/A